Determinants of Mortality and Mid-Term Outcomes After Transcarotid Artery Revascularization and Transfemoral Carotid Artery Stenting.
Jerry ZhuAjit RaoKelsey BergerMalika GopalAmey VrudhulaDaniel HanAgeliki VouyoukaWindsor TingDavid FinlaySung Yup KimRami TadrosMichael MarinPeter FariesPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2024)
The ongoing debate over the superiority of TCAR compared to tfCAS and CEA has been limited by a lack of comparative studies examining the impact of pre-operative symptoms on outcomes. Furthermore, data are scarce on mid-term outcomes for TCAR beyond the perioperative period. As a result, it remains uncertain whether the initial benefits of stroke and death reduction observed with TCAR over tfCAS persist beyond one year. Our study addresses these gaps in the literature, offering evidence to enable clinicians to assess the efficacy of TCAR for up to three years. Additionally, our study seeks to identify risk factors for postoperative mortality following TCAR, facilitating optimal patient stratification.
Keyphrases
- patients undergoing
- cardiovascular events
- systematic review
- type diabetes
- machine learning
- adipose tissue
- electronic health record
- transcatheter aortic valve replacement
- metabolic syndrome
- big data
- percutaneous coronary intervention
- depressive symptoms
- blood brain barrier
- antiplatelet therapy
- case control
- data analysis